Vimarsana
Biggest News Aggregation in the World

Nasdaq Ctxr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Ctxr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ctxr Today - Breaking & Trending Today

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Update - Vimarsana News

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Update

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 17,210,000 shares, a decrease of 7.2% from the September 30th total of 18,540,000 shares. Based on an average daily trading volume, of 997,100 shares, the days-to-cover […]

Citius Pharmaceuticals (NASDAQ:CTXR) Price Target Cut to $4.00 - Vimarsana News

Citius Pharmaceuticals (NASDAQ:CTXR) Price Target Cut to $4.00

Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) had its target price decreased by research analysts at HC Wainwright from $6.00 to $4.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 337.59% from the company’s […]

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Up 13.4% in May - Vimarsana News

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Up 13.4% in May

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 13,760,000 shares, an increase of 13.4% from the May 15th total of 12,130,000 shares. Based on an average daily volume of 1,450,000 shares, the short-interest ratio is […]

Source: wkrb13.com
Rocket Pool ETH (RETH) Self Reported Market Cap Achieves $639.56 Million - Vimarsana News

Rocket Pool ETH (RETH) Self Reported Market Cap Achieves $639.56 Million

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Rating) – Investment analysts at HC Wainwright decreased their Q3 2023 earnings per share estimates for Citius Pharmaceuticals in a report issued on Tuesday, May 30th. HC Wainwright analyst V. Bernardino now forecasts that the company will earn ($0.07) per share for the quarter, down from their previous estimate […]

Short Interest in Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Expands By 6.7% - Vimarsana News

Short Interest in Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Expands By 6.7%

Citius Pharmaceuticals, Inc. (NASDAQ:CTXR – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 13,600,000 shares, a growth of 6.7% from the April 15th total of 12,750,000 shares. Based on an average trading volume of 953,100 shares, the short-interest ratio is […]